Balaxi Pharmaceuticals Ltd.

NSE: BALAXI  SECTOR: Finance - Investment

880
+6.9 (0.79%)

Price Summary

Today's High

₹ 0

Today's Low

₹ 0

52 Week High

₹ 1080.2

52 Week Low

₹ 63.9

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.

Company Essentials

Market Cap

880 Cr.

Advances

0 Cr.

No. of Shares

1 Cr.

P/E

66.21

P/B

23.73

Face Value

₹ 10

Div. Yield

0%

Book Value (TTM)

₹  37.0823

Operating Revenue

45.6324 Cr.

Net Profit

6.4958 Cr.

Promoter Holding

72.86%

EPS (TTM)

₹  13.292

Sales Growth

235.645880224193 %

ROE

41.0700285779318 %

ROCE

58.8787587567335 %

Profit Growth

230.423724502772 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1w1m3m6m1Yr3Yr5Yr

* Prices are based on daily market changes.

Valuation Chart 1w1m3m6m1Yr3Yr5Yr

* The chart is based on the standalone earnings of the company.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Income Growth (in Cr.)

1 Year235.65%
3 Year∞%
5 Year226.1%

Profit Growth (in Cr.)

1 Year230.42%
3 Year239.96%
5 Year129.35%

ROE%

1 Year41.07%
3 Year26.28%
5 Year13.99%

ROCE %

1 Year58.88%
3 Year38.47%
5 Year21.72%

ROA%

29.5177766467937

PEG Ratio

147.51

PAT Margin (%)

14.2350610531114

EPS Growth(%)

0.448812248842765

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2019 72.86 0
Sep 2019 72.86 0
Jun 2019 73.23 0
Mar 2019 73.23 0
Dec 2018 73.24 0
* Figures given above are % of equity capital

 Strengths

  • Company has maintained a good ROA of 14.0017970299596% in last 3 years.
  • Company has a healthy Return on Equity (ROE) track record of 26.2826947845166%.
  • TThe company has been maintaining a healthy ROCE of 38.4677354120588% since last 3 years.
  • Operating Income has grown well for the company over past 3 years: 3 years CAGR %.
  • The company has delivered substantial profit growth of 239.957672405706% over past 3 years.
  • Promoters shareholding is 72.86%.

 Limitations

 Looks like the company does not have any serious limitations.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020
Operating Revenue 12.55 13.14 11.71 21.15 22.21
Other Income 0.62 0.7 1.17 1.47 0.52
Interest Expended 0 0 0 0 0
Operating Expenses 11.58 10.38 10.08 16.32 17.01
Total Provisions 0 0 0 0 0
Depreciation 0 0 0 0.01 0.03
Profit Before Tax 1.59 3.46 2.79 6.29 5.69
Tax 0.44 0.99 0.94 1.58 1.43
Net Profit 1.14 2.47 1.85 4.71 4.26

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Operating Income 0.05 0 0 13.6 45.63
Other Income 0 0 0 0.81 2.81
Interest 0.05 0.04 0 0 0.05
Operating Expenses 0.12 0.13 0.77 11.96 39.13
Total Provisions 0 0 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax -0.12 -0.17 -0.77 2.44 9.27
Tax -0.04 0 0 0.47 2.77
Profit After Tax -0.08 -0.17 -0.77 1.97 6.5
Adjusted EPS (Rs.) -0.26 -0.57 -2.53 6.47 6.5

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Equity and Liabilities
Share Capital 3.04 3.04 3.04 3.04 10
Total Reserves 0.11 -0.72 -1.49 0.48 18.11
Borrowings 0 0 0 0 0
Other N/C liabilities -0.04 0 0 0 0
Current liabilities 0.42 0.05 0.13 2.59 9.79
Total Liabilities 3.53 2.37 1.69 6.11 37.91
Assets
Loans 0 0 0 0 0
Net Block 0 0 0.01 0.01 0.19
Capital WIP 0 0 0 0 0
Investments 3.27 0 0 0 0.1
Other Loans 0 0.03 0.03 0.32 0.92
Other N/C Assets 0 0 0 0 0
Current Assets 0.26 2.34 1.65 5.78 36.7
Total Assets 3.53 2.37 1.69 6.11 37.91
* Other Non-current Liabilities include Net deferred Liabilities

Corporate Actions

Annual Reports

No Annual reports exist for this company.
Report us

Ratings & Research Reports

No Credit and Research reports exist for this company.
Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.
Report us

Company News

Balaxi Pharma. Stock Price Analysis and Quick Research Report. Is Balaxi Pharma. an attractive stock to invest in?

 

Around 2% of India's total population invests in financial assets. The penetration of the mutual fund industry in India is close to 7% (Based on the number of PAN cardholders). This under penetration of the mutual fund industry offers a huge opportunity for the industry to grow. Migration to financial savings, wider distribution and sustainable performance are expected to enable growth in the industry. Also, increasing financial literacy among investors, digitization and the number of mediums available tend to attract more investors to invest in the financial markets.

To understand the functions of the Balaxi Pharma. better, you must go through the following points:

Key Financials –

  • Profitability: Profit margin (PAT margin) of the company shows how well a company controls its cost. It is one of the important indicators to show the financial health of the company. Net profit of the company is Rs 6.4958 Cr and the compounded growth of profit in the past 3 years is 239.957672405706 %. The PAT margin of Balaxi Pharma. is 14.2350610531114 %.

  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Balaxi Pharma. , the EPS grew by 0.448812248842765 % YOY. 

 Financial Ratios –

  •  Return on Equity (ROE): The Company has a healthy ROE track record. The ROE of Balaxi Pharma. is at 41.0700285779318 % for the latest year.

  • P/E Ratio: Relative valuation metrics like the P/E ratio can be used to see if the stock of Balaxi Pharma. is worth at the current levels at Rs 873.1. The stock is trading at a current P/E ratio of 11.3919763539518 and the average historical P/E for the last 5 years was 3.45363307535824.

  • P/B ratio can be one of the best metrics to value such companies. Currently, Balaxi Pharma. is trading at a P/B of 23.7309983469202 . The average historical P/B for the last 5 years was 2.47207960239711. This can be compared with the Market price per share in order to know if the stock is undervalued or overvalued.

Brief about Balaxi Pharma.

X